Analysis of serious adverse events in a pediatric community-acquired pneumonia randomized clinical t...
Analysis of serious adverse events in a pediatric community-acquired pneumonia randomized clinical trial in Malawi
About this item
Full title
Author / Creator
Publisher
London: Nature Publishing Group UK
Journal title
Language
English
Formats
Publication information
Publisher
London: Nature Publishing Group UK
Subjects
More information
Scope and Contents
Contents
Amoxicillin is recommended as first-line antibiotic treatment for community-acquired pneumonia, the leading infectious cause of mortality in children aged less than 5 years. We conducted a double-blind, randomized controlled non-inferiority trial comparing 3- to 5-day amoxicillin treatment for non-severe chest-indrawing pneumonia in HIV-negative ch...
Alternative Titles
Full title
Analysis of serious adverse events in a pediatric community-acquired pneumonia randomized clinical trial in Malawi
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_dfac286d0a054428b18a9e41ba0a9333
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_dfac286d0a054428b18a9e41ba0a9333
Other Identifiers
ISSN
2045-2322
E-ISSN
2045-2322
DOI
10.1038/s41598-022-07582-w
